Silence Therapeutics – The GOLDen future of RNAi Research
Mark Rothera, President and CEO of Silence Therapeutics discusses RNAi research and how the company is applying its mRNAi GOLD™ platform to precisely ...
5326 articles
Mark Rothera, President and CEO of Silence Therapeutics discusses RNAi research and how the company is applying its mRNAi GOLD™ platform to precisely ...
Clinicians are acutely interested in delivering the best outcomes for their patients. Learn more on Health Professional Radio.
Alison Miles, a patient living with Pompe disease, a condition that develops when the body can't make a protein that breaks down a complex sugar, glycog...
Devon Christie, MD, is the Medical and Therapeutic Services Director with Numinus Wellness Inc., a Canadian-based company at the forefront of advancing ...
Hematology and Oncology at Jazz Pharmaceuticals, discusses the "Nothing Small About It" online program developed with leading cancer organizations focus...
Jared Silver, MD, PhD, Allergist Immunologist & Indication Lead for Mepolizumab, US Medical Affairs Respiratory at GSK discusses the recent FDA approval...
Lisa Anderson, CEO, President and co-founder of Paragonix Technologies, Inc., a company delivering a new standard in organ preservation and transport, d...
Shannon Resetich, Global Franchise Head, Rare Diseases at Sanofi Genzyme discusses the company's Humanitarian Aid Program started 30 years ago.
Alan Rechter, MD, an orthopedic surgeon, from Orthopoedic Associates in Houston, TX, discusses the newest method of effectively managing postoperative p...
Carla Mack, Global Head of Professional Affairs at Alcon discusses the company's latest innovation, TOTAL30®, the first-and-only monthly replacement, w...